Cytophenix
PrivateLast Round
Pre Seed
Oct 28, 2025
Total Funding Raised
$1.55M
Company Overview
Cytophenix operates in Healthcare & Life Sciences and is based in Perth. Its latest recorded funding round was a Pre Seed round in October 2025.
Cytophenix is a biotechnology company developing a medical diagnostic platform for rapid antimicrobial susceptibility testing to help clinicians make timely and informed antibiotic treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytophenix Comparables
Compare Cytophenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Microplate Dx | 86% | |
| iFAST Diagnostics | 86% | |
| Vivid Dx | 86% |
For institutional investors. Book with your work email.
Cytophenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 28, 2025 | ||||
| Grant | Sep 11, 2024 | ||||
| Accelerator | Jun 5, 2024 | ||||
| Grant | May 24, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cytophenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Purpose Ventures | Pre Seed |
| CUREator | Grant |
| Perth Angels | Pre Seed |
| La Ferla Ventures | Pre Seed |
| Brandon Capital | Grant |
| CSIRO ON Accelerate | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Grew 43% QoQ from 7 to 10 employees.
- Oct 28, 2025
$860K raised in Pre Seed round.
For institutional investors. Book with your work email.
Cytophenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cytophenix's valuation, stock price, and market status.
Is Cytophenix a public or private company?
Cytophenix is a private company.
What is the current stock price of Cytophenix?
Cytophenix is a private company, so its shares have no public market price. Caplight tracks Cytophenix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cytophenix worth (valuation)?
Valuation information for Cytophenix is not publicly available.
Can I buy Cytophenix stock?
Cytophenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cytophenix's last funding round?
Cytophenix's most recent funding round was Pre Seed on October 28, 2025.
Who are the main investors in Cytophenix?
Key investors in Cytophenix include Purpose Ventures.
Will Cytophenix IPO soon?
No public IPO plans have been announced for Cytophenix.
How can I track Cytophenix secondary market activity?
Caplight tracks bids, offers, and trades in Cytophenix's shares on secondary markets.